A
Alcista
Alcista · 25%BKYI
$0.91
Precio del escenario
$3.390
+0.804 (+23.72%)Al cierre
Loading chart…
- Máximo
- 3.920
- Apertura
- 3.250
- Precio medio ponderado por volumen
- 3.51
- Volumen
- 35.32M
- Capitalización
- 2.81M
- Mínimo
- 3.210
- Importe
- 123.85M
- EV/EBITDA, TTM
- -1.44
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform.
Análisis de IA of BIO-Key International Inc (BKYI)
ComprarBIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.
Recomendaciones de analistas (1)
Comprar
1 Comprar
0 Mantener
0 Vender
Actual: 3.39
Mínimo
—
Promedio
—
Máximo
—
Métricas de valoración
El PER previsto actual de BIO-Key International Inc (BKYI) es 0.00, frente a su media de 5 años de -4.50.
Escenarios de precio de Alphio AI para BKYI
Los precios por escenario son la última banda de previsión mensual del año en curso. Las probabilidades son pesos fijos del modelo (25 / 50 / 25), no garantías.
Cronología de eventos
Noticias
7.510-22NewsfilterBIO-key Deploys Biometric Solutions for Middle East Government Institution
- 7.510-13Newsfilter
BIO-key Partners with Middle East Government Agency for Enhanced Security
- 9.508-13Newsfilter
BIO-key Reports Q2 2026 Financial Results and Outlook
- 8.508-11Newsfilter
BIO-key Enters Warrant Inducement Agreement with Investor
- 7.508-10Newsfilter
BIO-key and Visualforma Awarded Contract for Portuguese National Security
Preguntas frecuentes sobre BKYI, respondidas por Alphio AI
BIO-key International, Inc. is a provider of workforce and customer identity and access management (IAM) solutions featuring passwordless, phoneless and token-less Identity-Bound Biometric (IBB) authentication. The Company’s IAM platform enables secure work-from-anywhere for enterprise, education, and government customers using secure multi-factor authentication (MFA). Its products include PortalGuard and PortalGuard Identity-as-a-Service (IDaaS) enterprise IAM, WEB-key biometric civil and large-scale ID infrastructure, MobileAuth mobile phone authentication application for iOS and Android, and quality accessory fingerprint scanner and FIDO-compliant hardware to provide complete solution for identity-innovating customers. Its PortalGuard is a cloud-based identity platform that allows its customers to integrate with any cloud or on-premise SaaS application, service or cloud host, as well as Windows device authentication through a single IAM platform. It operates in the Technology sector (SERVICES-PREPACKAGED SOFTWARE industry).
BIO-Key International Inc is a good buy right now due to its recent 57.49% price increase over the last 5 days and a gross margin of 87.19% in Q2 2026, indicating strong profitability potential. The current price of $2.63 is well below its Fibonacci resistance levels, suggesting room for growth. However, the main risk is the negative earnings per share of -0.56 reported in Q2 2026, which reflects ongoing financial challenges.
1 analysts cover BKYI: 1 rate it Buy, 0 Hold and 0 Sell.
Comunidad
Más ↗Aún no hay publicaciones
Regístrate o inicia sesión para participarEsta página es solo para investigación y no constituye asesoramiento de inversión. Los modelos pueden equivocarse. El rendimiento pasado no garantiza resultados futuros.